Organic cation uptake is enhanced in bcrp1-transfected MDCKII cells

Area of Science:

• Pharmacology
• Cell Biology
• Biochemistry

Background:

• Stably transfected cell models are crucial for studying drug-transporter interactions.
• An observed enhancement in organic cation accumulation in bcrp1-transfected MDCKII cells prompted further investigation.

Purpose of the Study:

• To explore the expression and functional impact of the cation transport system in bcrp1-transfected MDCKII cells.
• To investigate the relationship between bcrp1 and organic cation transporter 2 (OCT2) expression and function.

Main Methods:

• Transport assays using radiolabeled organic cations ([3H]-prazosin, [3H]-agmatine, [3H]-TEA, [14C]-choline) in wild-type and bcrp1-transfected MDCKII cells.
• Quantitative reverse transcription-polymerase chain reaction (RT-PCR) to assess mRNA levels of bcrp1, OCT2, and OCT3.
• Western blot analysis to determine protein expression levels of relevant transporters.

Main Results:

• Bcrp1-transfected cells showed significantly increased intracellular accumulation of organic cations agmatine, TEA, and choline compared to wild-type cells.
• RT-PCR revealed a 10-fold increase in OCT2 mRNA levels and Western blots showed a 3.5-fold increase in OCT2 protein expression in bcrp1-transfected cells.
• The enhanced OCT2 expression in bcrp1-transfected cells contributed to a significant increase in the uptake of several organic cations.

Conclusions:

• Upregulation of OCT2 in bcrp1-transfected MDCKII cells enhances organic cation uptake, mimicking endogenous OCT2 expression in kidney tubules.
• These findings underscore the importance of considering how recombinant transporter overexpression can influence endogenous transporters with overlapping substrate specificities.
• Understanding these interactions is vital for accurately predicting drug disposition and potential transporter-mediated toxicities.